These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22393910)

  • 41. Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.
    Popp AW; Isenegger J; Buergi EM; Buergi U; Lippuner K
    Eur Spine J; 2006 Jul; 15(7):1035-49. PubMed ID: 16474946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ; Clarke K
    J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gu Ling Pian, a traditional Chinese medicine, regulates function and OPG/RANKL synthesis of osteoblasts via the p38 MAPK pathway.
    Zhao Y; Li J; Liu Y; Yu KQ; Zhang J; Chen XG
    J Pharm Pharmacol; 2007 Aug; 59(8):1167-73. PubMed ID: 17725861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update on glucocorticoid-induced osteoporosis.
    Maricic M
    Rheum Dis Clin North Am; 2011 Aug; 37(3):415-31, vi. PubMed ID: 22023900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Glucocorticoid induced osteoporosis].
    Anić B; Mayer M
    Reumatizam; 2014; 61(2):105-12. PubMed ID: 25427404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation.
    Rauch A; Gossye V; Bracke D; Gevaert E; Jacques P; Van Beneden K; Vandooren B; Rauner M; Hofbauer LC; Haegeman G; Elewaut D; Tuckermann JP; De Bosscher K
    FASEB J; 2011 Apr; 25(4):1323-32. PubMed ID: 21233489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA; Hamdy NA
    Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects.
    Alesci S; De Martino MU; Ilias I; Gold PW; Chrousos GP
    Neuroimmunomodulation; 2005; 12(1):1-19. PubMed ID: 15756049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Glucocorticoid-induced osteoporosis].
    Tóth M; Tulassay Z
    Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
    Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
    N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glucocorticoid-induced osteoporosis: 2013 update.
    Mazzantini M; Di Munno O
    Reumatismo; 2014 Jul; 66(2):144-52. PubMed ID: 25069496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
    Liu XH; Kirschenbaum A; Yao S; Levine AC
    Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Glucocorticoid induced osteoporosis].
    Gutiérrez-Polo R
    An Sist Sanit Navar; 2003; 26 Suppl 3():63-80. PubMed ID: 14716359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
    Humphrey EL; Williams JH; Davie MW; Marshall MJ
    Bone; 2006 May; 38(5):652-61. PubMed ID: 16298558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteogenic growth peptide effects on primary human osteoblast cultures: potential relevance for the treatment of glucocorticoid-induced osteoporosis.
    Spreafico A; Frediani B; Capperucci C; Leonini A; Gambera D; Ferrata P; Rosini S; Di Stefano A; Galeazzi M; Marcolongo R
    J Cell Biochem; 2006 Jul; 98(4):1007-20. PubMed ID: 16795077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Drug-induced osteoporosis: glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2015 Sep; 25(9):1347-56. PubMed ID: 26320535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Corticosteroid-induced osteoporosis.
    Adachi JD; Bensen WG; Cividino A
    J Am Med Womens Assoc (1972); 1998; 53(1):25-30, 40. PubMed ID: 9458622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How to prevent steroid induced osteoporosis.
    Sambrook PN
    Ann Rheum Dis; 2005 Feb; 64(2):176-8. PubMed ID: 15647424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucocorticoid-Induced Osteoporosis: Management Challenges in Older Patients.
    Adler RA
    J Clin Densitom; 2019; 22(1):20-24. PubMed ID: 29941355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of corticosteroid-induced osteoporosis.
    Adachi JD; Olszynski WP; Hanley DA; Hodsman AB; Kendler DL; Siminoski KG; Brown J; Cowden EA; Goltzman D; Ioannidis G; Josse RG; Ste-Marie LG; Tenenhouse AM; Davison KS; Blocka KL; Pollock AP; Sibley J
    Semin Arthritis Rheum; 2000 Feb; 29(4):228-51. PubMed ID: 10707991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.